DEC 04, 2019 12:55 PM PST

Predicting Death with Clinical Immune Indicators

WRITTEN BY: Kara Marker

Immune and inflammation status could help doctors predict which individuals are most at-risk for death. Results from a new study mark the first step toward linking biomarkers of health with specific diseases and therapeutic targets.

Researchers made use of data from the 1999-2010 National Health and Examination Survey (NHANES) - including more than 31,000 participants - to study the ability of immune and inflammatory clinical indicators to predict human health outcomes. Senior author Jarrod Dalton, PhD, described the study as “investigating the predictive power of components of a patient’s white blood cell count.”

White blood cell count is a clinical indicator of health and part of the normal blood work completed during a typical health exam. The study found that low levels of one type of white blood cells, called lymphocytes, is linked with death from heart disease, cancer, and respiratory infections like influenza and pneumonia. The connection between these diseases and low lymphocyte levels, or lymphopenia, held true regardless of age, other blood-based immune markers, and clinical risk factors.

Lymphocytes make up anywhere from 20 to 40 percent of all white blood cells and include B cells, T cells, and natural killer (NK) cells. Important for the immune response to infection, lymphocyte levels can be abnormally low as a result of underproduction, cellular destruction, and spleen or lymph node blockages. Conditions like AIDS are a type of lymphopenia that is acquired rather than genetic.

The link between lymphopenia and mortality grew in cases where patients also presented with other blood abnormalities. This included elevated red blood cell distribution width and C-reactive protein levels, an indicator of inflammation.

Scientists are still working to elucidate the physiological mechanisms linking these biomarkers to specific diseases. After that, scientists can develop targeted therapies.

In the meantime, explains co-author Sadeer Al-Kindi, MD, they can “design systems that allow physicians to use pragmatic immune status indicators to ensure that the 10-20% of the general population at highest risk for mortality do not fall through the cracks of routine preventive care and early detection services."

Sources: Cleveland Clinic, JAMA Network Open, National Heart, Lung, and Blood Institute

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
APR 16, 2020
Health & Medicine
Structural Basis of Receptor Recognition by SARS-CoV-2
APR 16, 2020
Structural Basis of Receptor Recognition by SARS-CoV-2
As mortality and infection rates rise globally, it appears that SARS-CoV-2, the virus responsible for the COVID-19 pande ...
APR 22, 2020
Immunology
Scientists Engineer Custom Antiviral Receptors to Fight COVID-19
APR 22, 2020
Scientists Engineer Custom Antiviral Receptors to Fight COVID-19
The best offense may be a good defense in the fight against COVID-19. Researchers from the Duke-NUS Medical School are e ...
MAY 26, 2020
Immunology
The Hunt for Rare Immune Cells, to InfinityFlow and Beyond
MAY 26, 2020
The Hunt for Rare Immune Cells, to InfinityFlow and Beyond
The immune landscape is staggeringly complex, with a myriad of genetically and functionally distinct immune cell subpopu ...
JUL 15, 2020
Immunology
Immune Memory to Thwart Recurring Cancer
JUL 15, 2020
Immune Memory to Thwart Recurring Cancer
Preventing cancer from returning in the body is an integral part of any anti-cancer treatment plan. New discoveries from ...
JUL 30, 2020
Immunology
Gene Silencing Therapy Stops the Itch of Psoriasis
JUL 30, 2020
Gene Silencing Therapy Stops the Itch of Psoriasis
A team of Harvard researchers has identified a promising new approach for treating psoriasis — a topical lotion co ...
JUL 28, 2020
Immunology
Neonatal Origins of Chronic Inflammatory Disease
JUL 28, 2020
Neonatal Origins of Chronic Inflammatory Disease
From birth, our genes write the story of our lives. For many people who develop chronic immune and inflammatory diseases ...
Loading Comments...